Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Neoplasms, Second Primary × Tobacco Use Cessation Devices × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 2 Smoking Cessation 1 Neoplasms, Second Primary 1 Hand-Foot Syndrome 1 Cigarette Smoking 1 Chemotherapy-Related Cognitive Impairment 1 Behavior, Addictive 1

Interventions

Leucovorin 2 Irinotecan 2 Fluorouracil 2 dostarlimab 1 avelumab 1 Varenicline 1 Tobacco Use Cessation Devices 1 Temozolomide 1 Radiotherapy 1 Panitumumab 1 Nicotine Chewing Gum 1 Cetuximab 1 Bupropion 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04634071 2026-02-02

TTOP

University of Kentucky

Phase 2 Completed

Smoking Cessation, Neoplasms, Second Primary, Behavior, Addictive

Data powered by HemOnc (CC BY 4.0) Colophon ⚡